Strides Pharma

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE939A01011
NSEID: STAR
BSEID: 532531

INR

880.15

-5.5 (-0.62%)

BSENSE

Dec 05

BSE+NSE Vol: 58.7 k

{
  "main_header": {
    "sid": 688428,
    "name": "Strides Pharma",
    "stock_name": "Strides Pharma",
    "full_name": "Strides Pharma Science Ltd",
    "name_url": "stocks-analysis/strides-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "880.15",
    "chg": -5.5,
    "chgp": "-0.62%",
    "dir": -1,
    "prev_price": "885.65",
    "mcapval": "8,112.58 Cr",
    "mcap": "Small Cap",
    "scripcode": 532531,
    "symbol": "STAR",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE939A01011",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "58.7 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/strides-pharma-688428-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Strides Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-strides-pharma-fallingrising-3736113",
        "imagepath": "",
        "date": "2025-11-29 00:43:26",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Strides Pharma’s stock has experienced a modest pullback over the past week, declining by 2.06%, in contrast to the Sensex which gained 0.56% during the same period. The stock has underperformed its sector by 2.03% on the day, continuing a two-day losing streak that has resulted in a cumulative fall of 3.06%. This short-term weakness is reflected in the stock trading below its 5-day and 20-day moving averages, although it remains comfortably above its 50-day, 100-day, and 200-day averages, signalling that the longer-term trend remains intact.</p>\n<p>Investor participation has also waned recently, with delivery volumes on 27 Nov dropping sharply by 68.69% compared to the five-day average. This decline in trading activity suggests a caut..."
      },
      {
        "title": "Is Strides Pharma technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-strides-pharma-technically-bullish-or-bearish-3734647",
        "imagepath": "",
        "date": "2025-11-28 08:21:30",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Overview of Current Technical Trend</strong></p>\n<p>As of 27 Nov 2025, Strides Pharma’s overall technical trend has moderated from a clear bullish stance to a mildly bullish one. This subtle shift reflects a market environment where upward momentum persists but is tempered by emerging bearish signals. The stock’s current price stands at ₹892.00, slightly below the previous close of ₹903.80, indicating some short-term pressure.</p>\n<p>The 52-week price range remains wide, with a high of ₹1,024.90 and a low of ₹530.70, underscoring significant volatility over the past year. Today’s trading range between ₹885.00 and ₹912.75 further illustrates this variability.</p>\n<p><strong>Key Technical Indicators: Mixed Signals</strong></p>\n<p>Examining the technical indicators in detail reveals a blend of ..."
      },
      {
        "title": "Strides Pharma Science Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-sees-technical-momentum-shift-amid-mixed-signals-3734619",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/StridesPharmaSc_technicaldot_3734619.png",
        "date": "2025-11-28 08:04:16",
        "description": "Strides Pharma Science has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. While the stock’s price momentum shows signs of mild bullishness, several technical parameters present a mixed picture, underscoring the importance of a detailed analysis for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Strides Pharma’s Evaluation Revised Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/strides-pharma-upgraded-from-sell-to-hold-by-marketsmojo-on-29-sep-2025-3733223",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/StridesPharma_mojoScore_3733223.png",
        "date": "2025-11-27 10:05:56",
        "description": "Strides Pharma has experienced a revision in its market evaluation, reflecting a nuanced shift in its financial and technical outlook. This adjustment comes amid a backdrop of steady stock returns and a complex fundamental profile, highlighting the evolving investor perspective on the pharmaceutical company’s prospects."
      },
      {
        "title": "Strides Pharma Science Exhibits Bullish Momentum Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-shows-bullish-momentum-amid-technical-upgrades-3732520",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/StridesPharmaSc_technicaldot_3732520.png",
        "date": "2025-11-27 08:05:11",
        "description": "Strides Pharma Science has demonstrated a notable shift in price momentum, reflecting a bullish technical trend supported by key indicators such as MACD and moving averages, while some oscillators present a more nuanced picture. The stock’s recent performance contrasts with broader market benchmarks, highlighting its distinct trajectory within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Strides Pharma Science Exhibits Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-technical-momentum-shifts-amid-mixed-indicator-signals-3730291",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/StridesPharmaSc_technicaldot_3730291.png",
        "date": "2025-11-26 08:05:47",
        "description": "Strides Pharma Science has experienced a nuanced shift in its technical landscape, reflecting a complex interplay of momentum indicators and moving averages. Recent market data reveals a transition from a bullish to a mildly bullish trend, underscoring evolving investor sentiment within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Strides Pharma Science Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-technical-momentum-shifts-signal-bullish-outlook-amid-market-volatility-3727541",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/StridesPharmaSc_technicaldot_3727541.png",
        "date": "2025-11-25 08:08:54",
        "description": "Strides Pharma Science has exhibited a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. As the stock navigates these changes, investors and market watchers are closely analysing key indicators such as MACD, RSI, moving averages, and volume trends to gauge its near-term trajectory within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Strides Pharma Science Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-technical-momentum-shifts-amid-mixed-market-signals-3723820",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/StridesPharmaSc_technicaldot_3723820.png",
        "date": "2025-11-24 08:03:30",
        "description": "Strides Pharma Science has experienced a notable shift in its technical parameters, reflecting a nuanced change in price momentum and market sentiment. While some indicators maintain a bullish stance, others suggest caution, highlighting a complex landscape for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Why is Strides Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-strides-pharma-fallingrising-3686949",
        "imagepath": "",
        "date": "2025-11-10 22:05:20",
        "description": "As of 10-Nov, Strides Pharma Science Ltd is experiencing a decline in its stock price, currently at 929.00, which reflects a decrease of 17.95 or 1.9%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in a total decline of 5.61% over the past week. Today's trading saw the stock reach an intraday low of Rs 922, with a weighted average price indicating more volume traded closer to this low. Despite the company declaring positive results for the last nine consecutive quarters, including significant growth in operating profit and attractive valuations compared to peers, the stock's performance has been negatively impacted by a 14.7% decline in profits over the past year.\n\nIn the broader market context, Strides Pharma's recent performance contrasts with the Sensex, which has only decreased by 0.53% over the same one-week period. While the stock has shown strong re..."
      }
    ],
    "total": 620,
    "sid": "688428",
    "stock_news_url": "https://www.marketsmojo.com/news/strides-pharma-science-688428"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "03-Dec-2025",
      "details": "Intimation under reg 30 - Resignation of Group CHRO",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "17-Nov-2025",
      "details": "Schedule of Analyst/ Institutional Investors Meet",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "05-Nov-2025",
      "details": "Transcript of Earnings Call pertaining to unaudited Financial Results of the Company for the quarter and half year ended September 30 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Strides Pharma Science Ltd has declared <strong>40%</strong> dividend, ex-date: 22 Jul 25",
          "dt": "2025-07-22",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Strides Pharma falling/rising?

2025-11-29 00:43:26

Recent Price Movement and Market Context

Strides Pharma’s stock has experienced a modest pullback over the past week, declining by 2.06%, in contrast to the Sensex which gained 0.56% during the same period. The stock has underperformed its sector by 2.03% on the day, continuing a two-day losing streak that has resulted in a cumulative fall of 3.06%. This short-term weakness is reflected in the stock trading below its 5-day and 20-day moving averages, although it remains comfortably above its 50-day, 100-day, and 200-day averages, signalling that the longer-term trend remains intact.

Investor participation has also waned recently, with delivery volumes on 27 Nov dropping sharply by 68.69% compared to the five-day average. This decline in trading activity suggests a caut...

Is Strides Pharma technically bullish or bearish?

2025-11-28 08:21:30

Overview of Current Technical Trend

As of 27 Nov 2025, Strides Pharma’s overall technical trend has moderated from a clear bullish stance to a mildly bullish one. This subtle shift reflects a market environment where upward momentum persists but is tempered by emerging bearish signals. The stock’s current price stands at ₹892.00, slightly below the previous close of ₹903.80, indicating some short-term pressure.

The 52-week price range remains wide, with a high of ₹1,024.90 and a low of ₹530.70, underscoring significant volatility over the past year. Today’s trading range between ₹885.00 and ₹912.75 further illustrates this variability.

Key Technical Indicators: Mixed Signals

Examining the technical indicators in detail reveals a blend of ...

Strides Pharma Science Technical Momentum Shifts Amid Mixed Indicator Signals

2025-11-28 08:04:16

Strides Pharma Science has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. While the stock’s price momentum shows signs of mild bullishness, several technical parameters present a mixed picture, underscoring the importance of a detailed analysis for investors navigating the Pharmaceuticals & Biotechnology sector.

Strides Pharma’s Evaluation Revised Amid Mixed Financial Signals

2025-11-27 10:05:56

Strides Pharma has experienced a revision in its market evaluation, reflecting a nuanced shift in its financial and technical outlook. This adjustment comes amid a backdrop of steady stock returns and a complex fundamental profile, highlighting the evolving investor perspective on the pharmaceutical company’s prospects.

Strides Pharma Science Exhibits Bullish Momentum Amid Mixed Technical Signals

2025-11-27 08:05:11

Strides Pharma Science has demonstrated a notable shift in price momentum, reflecting a bullish technical trend supported by key indicators such as MACD and moving averages, while some oscillators present a more nuanced picture. The stock’s recent performance contrasts with broader market benchmarks, highlighting its distinct trajectory within the Pharmaceuticals & Biotechnology sector.

Strides Pharma Science Exhibits Mixed Technical Signals Amid Price Momentum Shift

2025-11-26 08:05:47

Strides Pharma Science has experienced a nuanced shift in its technical landscape, reflecting a complex interplay of momentum indicators and moving averages. Recent market data reveals a transition from a bullish to a mildly bullish trend, underscoring evolving investor sentiment within the Pharmaceuticals & Biotechnology sector.

Strides Pharma Science Technical Momentum Shifts Amid Mixed Market Signals

2025-11-25 08:08:54

Strides Pharma Science has exhibited a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. As the stock navigates these changes, investors and market watchers are closely analysing key indicators such as MACD, RSI, moving averages, and volume trends to gauge its near-term trajectory within the Pharmaceuticals & Biotechnology sector.

Strides Pharma Science Sees Mixed Technical Signals Amid Price Momentum Shift

2025-11-24 08:03:30

Strides Pharma Science has experienced a notable shift in its technical parameters, reflecting a nuanced change in price momentum and market sentiment. While some indicators maintain a bullish stance, others suggest caution, highlighting a complex landscape for investors in the Pharmaceuticals & Biotechnology sector.

Why is Strides Pharma falling/rising?

2025-11-10 22:05:20

As of 10-Nov, Strides Pharma Science Ltd is experiencing a decline in its stock price, currently at 929.00, which reflects a decrease of 17.95 or 1.9%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in a total decline of 5.61% over the past week. Today's trading saw the stock reach an intraday low of Rs 922, with a weighted average price indicating more volume traded closer to this low. Despite the company declaring positive results for the last nine consecutive quarters, including significant growth in operating profit and attractive valuations compared to peers, the stock's performance has been negatively impacted by a 14.7% decline in profits over the past year. In the broader market context, Strides Pharma's recent performance contrasts with the Sensex, which has only decreased by 0.53% over the same one-week period. While the stock has shown strong re...

View All News